Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapies directed at the basic defect in cystic fibrosis.

Clinics in chest medicine - 1 Sept 1998

Zeitlin P L

Abstract excerpt

There are over 600 unique mutations in the cystic fibrosis (CF) gene that can be classified in five general categories with respect to specific defect. Through basic research into the genetic and physiologic consequences of these mutations, it has become possible to design genotype-specific therapeutic strategies. New pharmaceutical agents are under development for the rescue of defective cystic fibrosis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chloride Channels
Share to Cystic Fibrosis
Share to Cystic Fibrosis Transmembrane Conductance Regulator

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Therapy

Share to Mutation

Share to RNA, Messenger

Source

Identifiers

PMID: 9759553
DOI: 10.1016/s0272-5231(05)70097-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapies directed at the basic defect in cystic fibrosis.PMID 9759553Read ↗

New treatments targeting the basic defects in cystic fibrosis.Semantic proximity Read ↗

New Therapies to Correct the Cystic Fibrosis Basic Defect.Semantic proximity Read ↗

Changing the Paradigm - Treating the Basic Defect in Cystic Fibrosis.Semantic proximity Read ↗

Genetics of cystic fibrosis: CFTR mutation classifications toward genotype-based CF therapies.Semantic proximity Read ↗

Cystic fibrosis: therapies targeting specific gene defects.Semantic proximity Read ↗

Cystic fibrosis transmembrane conductance regulator intracellular processing, trafficking, and opportunities for mutation-specific treatment.Semantic proximity Read ↗

Emerging medicines to improve the basic defect in cystic fibrosis.Semantic proximity Read ↗

Advances in the diagnosis and treatment of cystic fibrosis.Semantic proximity Read ↗

Recent advances in developing therapeutics for cystic fibrosis.Semantic proximity Read ↗

Pharmacogenetics of cystic fibrosis treatment.Semantic proximity Read ↗

Development of novel therapeutics for all individuals with CF (the future goes on).Semantic proximity Read ↗

Cystic fibrosis: exploiting its genetic basis in the hunt for new therapies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.